NEWARK, Calif. (AP) 鈥� NEWARK, Calif. (AP) 鈥� Protagonist Therapeutics Inc. (PTGX) on Wednesday reported second-quarter net income of $162.8 million.
The Newark, California-based company said it had profit of $2.29 per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $2.11 per share.
The biopharmaceutical company posted revenue of $213.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $220.3 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/PTGX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
